XLR Medical Corp. entered into a non-binding letter of intent to acquire CBD Brand Partners, LLC from Mammoth Crest Capital, LLC.
March 08, 2021
Share
XLR Medical Corp. (OTCPK:XLRM) entered into a non-binding letter of intent to acquire CBD Brand Partners, LLC from Mammoth Crest Capital, LLC on February 10, 2021. XLR Medical will issue 10,000 shares of Series A Preferred Stock, 800 shares of Series B Preferred Stock and 1,200,000 shares of Series C Preferred Stock to holders of CBD. CBD Brand Partners pending completion of its due diligence process.
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 
